Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD): interim (month 6) analysis of clinical safety and efficacy.

Source:http://linkedlifedata.com/resource/pubmed/id/12652226

Download in:

View as

General Info

PMID
12652226